Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 27 October 2009, doi:10.1136/bmj.b4380
Cite this as: BMJ 2009;339:b4380
Patients should be treated aggressively for modifiable cardiovascular risk factors
| The first 150 words of the full text of this article appear below. |
In the linked systematic review (doi:10.1136/bmj.b3914), Schürks and colleagues assess the association between migraine and cardiovascular disease, including stroke, myocardial infarction, and death as a result of cardiovascular disease.1
Migraine is a highly prevalent chronic condition characterised by a hyper-responsive nervous system that predisposes to recurrent episodes of severe headache and autonomic disturbance.2 Roughly a quarter of people who have migraine experience temporary neurological symptoms, known as aura, before some or all of their headaches. Aura is distinguished from other causes of brief recurrent neurological disturbance, such as transient ischaemic attacks, by its gradual onset and disappearance, the presence of both positive and negative features, and its duration of an hour or less.
Visual disturbances are the most common sort of aura, although sensory or motor auras can also occur. Patients with aura can be identified using the visual aura rating scale (table
), which assigns a point
Elizabeth Loder, chief, division of headache and pain
1 Department of Neurology, Brigham and Womens/Faulkner Hospitals and Harvard Medical School, Boston, MA 02130 USA
eloder@partners.org
Read all Rapid Responses